CIK 0001649904 · Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 462159271
- Phone
- 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- 4 Planned sale Chief Technical Officer sold 794 shares at an average $57.51 ($45,663)
- 4 Planned sale EVP, Head of North America sold 5,216 shares at an average $58.64 ($305,846)
- 4 Planned sale Chief Human Resources Officer sold 701 shares at an average $57.51 ($40,315)
- 4 Planned sale Chief Financial Officer sold 1,296 shares at an average $57.51 ($74,533)
- 4 Planned sale EVP, Head of North America sold 3,066 shares at an average $60.55 ($185,640)
- 4 Open-market sale Chief Financial Officer sold 1,678 shares at $59.43 ($99,724)
- 4 Open-market sale Chief Technical Officer sold 1,281 shares at $59.43 ($76,130)
- 4 Open-market sale President and CEO sold 4,278 shares at $59.43 ($254,242)
- 4 Open-market sale EVP, Head of North America sold 1,447 shares at $59.43 ($85,995)
- 4 Open-market sale Chief Human Resources Officer sold 902 shares at $59.43 ($53,606)
- 4 Planned sale EVP, Head of North America sold 66,861 shares at an average $66.33 ($4,434,882)
- 4 Planned sale Chief Technical Officer sold 13,281 shares at an average $66.44 ($882,341)
- 4/A Option exercise Chief Technical Officer acquired 69,160 shares (option exercise)
- 4 Planned sale Chief Human Resources Officer sold 9,375 shares at an average $62.50 ($585,940)
- 4 Planned sale Director sold 31,751 shares at $52.40 ($1,663,803)
- 4 Planned sale Chief Human Resources Officer sold 4,099 shares at $50.03 ($205,062)
- 4 Planned sale Director sold 20,700 shares at an average $49.71 ($1,028,991)
- 4 Planned sale Director sold 37,241 shares at $50.45 ($1,878,700)
- 4 Planned sale Chief Human Resources Officer sold 3,200 shares at $50.01 ($160,018)
- 4 Planned sale Director sold 4,300 shares at $50.01 ($215,029)
Page 6 of 22 · 430 filings